Recruiting OBSERVATIONAL NCT05017142

Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)

Swiss Pediatric Inflammatory Bain Disease Cohort Study

Sponsor: Anna Mueller Grocholski-Stiftung

Conditions Acute Disseminated Encephalomyelitis Anti-AMPAR-1/2 Associated Autoimmune Encephalitis Anti-CASPR-2 Associated Autoimmune Encephalitis Anti-GABAR-1/2 Associated Autoimmune Encephalitis Anti-GAD65 Associated Autoimmune Encephalitis Anti-Lgi-1 Associated Autoimmune Encephalitis Anti-NMDAR Encephalitis CNS Lupus CNS Sarcoidosis CNS Vasculitis Hashimoto Encephalitis Multiple Sclerosis Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) Neuromyelitis Optica Spectrum Disorder Onconeuronal Antibody (Hu, Ri, Yo, Amphiphysin, CRMP-5, Ma-1, Ma-2, SOX-1) Associated Autoimmune Encephalitis Optic Neuritis Rasmussen Encephalitis Transverse Myelitis

Updated 7 times since 2021 Last updated: Dec 11, 2024 Started: Apr 14, 2020 Primary completion: Jan 1, 2071 Completion: Jan 1, 2071

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05017142, this observational or N/A phase trial focuses on Acute Disseminated Encephalomyelitis and Anti-AMPAR-1/2 Associated Autoimmune Encephalitis and remains actively recruiting participants. Sponsored by Anna Mueller Grocholski-Stiftung, it has been updated 7 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Recruiting
Jan 2025 — Sep 2025 [monthly]

Recruiting
Sep 2024 — Jan 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Jul 2023 — Jul 2024 [monthly]

Recruiting

▶ Show 2 earlier versions

Apr 2023 — Jul 2023 [monthly]

Recruiting
Sep 2021 — Apr 2023 [monthly]

Recruiting

First recorded

Apr 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Anna Mueller Grocholski-Stiftung
Biogen
Centre Hospitalier Universitaire Vaudois
Ente Ospedaliero Cantonale, Bellinzona
Fondation Johanna Dürmüller-Bol
Gottfried und Julia Bangerter- Rhyner-Stiftung, Basel
Hôpital Fribourgeois
Insel Gruppe AG, University Hospital Bern
Kantonsspital Aarau
Kantonsspital Graubünden
Kantonsspital Winterthur KSW
Luzerner Kantonsspital
Novartis
Ostschweizer Kinderspital
Roche Pharma (Switzerland) Ltd
Sanofi
Schweizerische Multiple Sklerose Gesellschaft
University Children's Hospital Basel
University Children's Hospital, Zurich
University Hospital, Geneva
University of Bern

Data source: University of Bern

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aarau, Switzerland , Basel, Switzerland , Bellinzona, Switzerland , Bern, Switzerland , Chur, Switzerland , Fribourg, Switzerland , Geneva, Switzerland , Lausanne, Switzerland , Lucerne, Switzerland , Sankt Gallen, Switzerland and 2 more locations